This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Penwest Pharmaceuticals Company, Other. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2013
Title: The Innovations of Raymond Higgins
Introduction
Raymond Higgins is an accomplished inventor based in New Milford, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of two patents to his name, Higgins has demonstrated a commitment to advancing medical treatments through his inventions.
Latest Patents
Higgins' latest patents include a delayed release dosage form and a chronotherapeutic dosage form. The delayed release pharmaceutical formulation comprises a core containing an active agent, such as a drug, and a delayed release compression coating made from a natural or synthetic gum applied to the surface of the core. His chronotherapeutic pharmaceutical formulation also features a core with an active agent and a similar delayed release compression coating, emphasizing the importance of timing in drug delivery.
Career Highlights
Throughout his career, Higgins has worked with notable companies, including Penwest Pharmaceuticals Company. His work has focused on creating formulations that enhance the effectiveness of medications, ensuring that patients receive the right dosage at the right time.
Collaborations
Higgins has collaborated with talented individuals in the pharmaceutical industry, including Anand R Baichwal and Jaclyn Cobb. These partnerships have contributed to the success of his innovative projects and have helped to push the boundaries of pharmaceutical science.
Conclusion
Raymond Higgins is a notable inventor whose work in delayed release and chronotherapeutic dosage forms has the potential to improve patient outcomes in the pharmaceutical field. His contributions reflect a dedication to innovation and a desire to enhance medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile